Topical bioavailability of diclofenac from locally-acting, dermatological formulations

被引:44
作者
Cordery, S. F. [1 ]
Pensado, A. [1 ]
Chiu, W. S. [1 ]
Shehab, M. Z. [1 ]
Bunge, A. L. [2 ]
Delgado-Charro, M. B. [1 ]
Guy, R. H. [1 ]
机构
[1] Univ Bath, Dept Pharm & Pharmacol, Bath, Avon, England
[2] Colorado Sch Mines, Chem & Biol Engn, Golden, CO 80401 USA
关键词
Diclofenac; Skin; Topical bioavailability; Topical bioequivalence; Dermato-pharmacokinetics; HUMAN STRATUM-CORNEUM; IN-VIVO; PERCUTANEOUS-ABSORPTION; DRUG PRODUCTS; BIOEQUIVALENCE; SKIN; VITRO;
D O I
10.1016/j.ijpharm.2017.06.063
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Assessment of the bioavailability of topically applied drugs designed to act within or beneath the skin is a challenging objective. A number of different, but potentially complementary, techniques are under evaluation. The objective of this work was to evaluate in vitro skin penetration and stratum corneum tape-stripping in vivo as tools with which to measure topical diclofenac bioavailability from three approved and commercialized products (two gels and one solution). Drug uptake into, and its subsequent clearance from, the stratum corneum of human volunteers was used to estimate the input rate of diclofenac into the viable skin layers. This flux was compared to that measured across excised porcine skin in conventional diffusion cells. Both techniques clearly demonstrated (a) the superiority in terms of drug delivery from the solution, and (b) that the two gels performed similarly. There was qualitative and, importantly, quantitative agreement between the in vitro and in vivo measurements of drug flux into and beyond the viable skin. Evidence is therefore presented to support an in vivo - n vitro correlation between methods to assess topical drug bioavailability. The potential value of the stratum corneum tapestripping technique to quantify drug delivery into (epi) dermal and subcutaneous tissue beneath the barrier is demonstrated. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:55 / 64
页数:10
相关论文
共 22 条
[11]   Improved Bioequivalence Assessment of Topical Dermatological Drug Products Using Dermatopharmacokinetics [J].
N'Dri-Stempfer, Berthe ;
Navidi, William C. ;
Guy, Richard H. ;
Bunge, Annette L. .
PHARMACEUTICAL RESEARCH, 2009, 26 (02) :316-328
[12]   Bioequivalence of Topical Clotrimazole Formulations: An Improved Tape Stripping Method [J].
Parfitt, Natalie Rae ;
Skinner, Michael ;
Bon, Charles ;
Kanfer, Isadore .
JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 2011, 14 (03) :347-357
[13]   Pharmacokinetics-Based Approaches for Bioequivalence Evaluation of Topical Dermatological Drug Products [J].
Raney, Sam G. ;
Franz, Thomas J. ;
Lehman, Paul A. ;
Lionberger, Robert ;
Chen, Mei-Ling .
CLINICAL PHARMACOKINETICS, 2015, 54 (11) :1095-1106
[14]   Novel Imaging Method to Quantify Stratum Corneum in Dermatopharmacokinetic Studies: Proof-of-Concept with Acyclovir Formulations [J].
Russell, Lisa M. ;
Guy, Richard H. .
PHARMACEUTICAL RESEARCH, 2012, 29 (12) :3362-3372
[15]   Biological models to study skin permeation [J].
Sekkat, N ;
Guy, RH .
PHARMACOKINETIC OPTIMIZATION IN DRUG RESEARCH: BIOLOGICAL, PHYSICOCHEMICAL, AND COMPUTATIONAL STRATEGIES, 2001, :155-172
[16]  
Shah V, 2015, TOPICAL DRUG BIOAVAI
[17]   Percutaneous absorption of 4-cyanophenol from freshly contaminated soil in vitro: Effects of soil loading and contamination concentration [J].
Touraille, GD ;
McCarley, KD ;
Bunge, AL ;
Marty, JP ;
Guy, RH .
ENVIRONMENTAL SCIENCE & TECHNOLOGY, 2005, 39 (10) :3723-3731
[18]  
TSAI JC, 1991, INT J PHARM, V68, P127
[19]  
U.S. Food and Drug Administration, 2001, STAT APPR EST BIOEQ
[20]  
US FDA, 1998, TOP DERM DRUG PROD N